Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

SIMPLE SUMMARY: The field of liquid biopsy is rapidly evolving. Techniques that improve accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a tool to guide their clinical practice. The assessment of minimal or microscopic residual disease (MRD) after oncological...

Descripción completa

Detalles Bibliográficos
Autores principales: Honoré, Natasha, Galot, Rachel, van Marcke, Cédric, Limaye, Nisha, Machiels, Jean-Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582541/
https://www.ncbi.nlm.nih.gov/pubmed/34771526
http://dx.doi.org/10.3390/cancers13215364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582541/
https://www.ncbi.nlm.nih.gov/pubmed/34771526
http://dx.doi.org/10.3390/cancers13215364

Ejemplares similares